MYRIAD ASSET MANAGEMENT US LP – Halozyme Therapeutics, Inc. Transaction History
MYRIAD ASSET MANAGEMENT US LP portfolio value:
$0
portfolio value
MYRIAD ASSET MANAGEMENT US LP quarter portfolio value change:
-10.14%
quarter
Halozyme Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -100.00% | -77K shares | -3.38M | $39.54 | 0 |
| Q2 2022 | share | Increase | 0.00% | 77K shares | 3.38M | $44 | 77K |